Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing etodolac (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
COX-2 inhibitor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely etodolac 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etodolac 300mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etodolac 600mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Celecoxib 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Celecoxib-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etodolac 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etodolac 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely etodolac 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etodolac 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing valdecoxib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valdecoxib 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely valdecoxib 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nabumetone (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rofecoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Meloxicam (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib 40mg injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib 40mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib 90mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib 120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib 40mg injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib 40mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valdecoxib 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Celecoxib |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etoricoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Valdecoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Deracoxib |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Firocoxib |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lumiracoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nimesulide (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parecoxib sodium (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketorolac tromethamine |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketorolac |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Etodolac (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nepafenac (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibuprofen sodium |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibuprofen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibuprofen sodium dihydrate (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ibuprofen lysine (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexibuprofen |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexketoprofen trometamol (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dexketoprofen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naproxen sodium (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naproxen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fenoprofen |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fenoprofen calcium |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alminoprofen |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polmacoxib |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|